SCHEMBL3201201

SCHEMBL3201201

CCOc1cc(N(Cc2cncs2)c2cccc(C(=O)OC(C)(C)C)c2)ccc1OC(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.36
RAB9A P51151 3/20 0.36
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
TSHR P16473 1/20 0.35
HDAC6 Q9UBN7 2/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.33
SREBF1 P36956 2/20 0.32
SLC7A5 Q01650 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPK14 Q16539 1/20 0.32
PDE4D Q08499 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3216620 0.93 HDAC6 (0.34) HDAC6LMNATRPM8SLC7A5PDE4D
SCHEMBL3125802 0.93 RAB9A (0.39) HRH4RAB9AMEN1KMT2AHDAC6
SCHEMBL3219592 0.93 NR1H2 (0.40) HRH4RAB9ANR1H2NR1H3LMNA
SCHEMBL3203001 0.92 POLB (0.35) RAB9AMEN1KMT2ATSHRHDAC6
SCHEMBL3122650 0.91 SLC7A5 (0.32) KMT2AHDAC6LMNAMAPTSLC7A5
SCHEMBL3123577 0.90 CTSL (0.35) KMT2ATSHRHDAC6LMNAMAPT
SCHEMBL3128993 0.89 HRH4 (0.39) HRH4RAB9AMEN1KMT2ATSHR
SCHEMBL3126048 0.88 SREBF1 (0.41) HRH4RAB9ANR1H2NR1H3TSHR
SCHEMBL3133400 0.88 PDE4D (0.41) PDE4D
SCHEMBL3126060 0.86 HDAC6 (0.37) HRH4RAB9AHDAC6TRPM8PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B HRH4 442/4885RAB9A 2160/4885NR1H2 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.